Results 81 to 90 of about 10,635 (224)

Changes in (A) CDAI, (B) SDAI, (C) CRP, and (D) HAQ-DI from the baseline to the IFX measurement point.

, 2021
The left figures show the data of patients with IFX level
Shunsaku Nakagawa (430323), Kotoko Yokoyama (11559147), Masaya Denda (3323322), Koichi Murata (164555), Hiromu Ito (164599), Makoto Hayakari (3134937), Yasuaki Ikemi (3615404), Atsushi Yonezawa (784929), Noriko Iwamoto (2073397), Sho Masui (11559144), Masao Tanaka (107633), Miyuki Nakamura (8159133), Kazuo Matsubara (647154), Kazuto Nakae (11559141), Kotaro Itohara (11559150), Kosaku Murakami (198978), Takayuki Nakagawa (202988), Satoshi Imai (124356), Takashi Shimada (234606), Motomu Hashimoto (388292), Ryu Watanabe (4025591)   +20 more
core   +1 more source

Prevalence of Depressive Disorders in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis of Studies With Diagnoses Verified Using Structured Interviews

JCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background Although depressive symptoms are highly prevalent in IBD based on questionnaire estimates, the prevalence of stringently diagnosed depression in IBD is unclear. This is important because higher‐intensity treatments for depression are only recommended in this subgroup.
Liling Xiao, Allan H. Young, Calum D. Moulton   +2 more
wiley   +1 more source

Association between dietary antioxidant intake and overweight/obesity risk among children and adolescents: a cross-sectional analysis from NHANES 2011–2016

Frontiers in Nutrition
ObjectiveOverweight and obesity among children and adolescents has emerged as a critical global public health issue. Oxidative stress, a key factor in obesity-related inflammation and metabolic dysregulation, underscore the importance of dietary ...
Jinwen Chen, Changhong Shi
doaj   +1 more source

Dose Intensification of Vedolizumab in Nonresponders With Active Crohn's Disease: Lessons From LOVE‐CD

JCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background Dose intensification of vedolizumab (VDZ) in patients with Crohn's disease (CD) with secondary loss of response has been reported to be effective. However, evidence for its effectiveness in primary nonresponders is inconsistent and largely based on retrospective studies.
L. Oldenburg, F. Baert, P. Bossuyt, T. Molnár, M. Löwenberg, G. D'Haens   +5 more
wiley   +1 more source

Box and whisker plots illustrating the changes in the disease activity in the patient cohort as assessed by CDAI (a) and DAS 28 (b).

, 2022
The median disease activities at different time points were compared by the Kruskal-Wallis test (with Dunn’s post-hoc analysis). The drops in the median disease activity down the timeline were statistically significant (p < 0.05).
Keerthie Dissanayake (9047032), Jayampathy Dissanayake (14192806), Chandrika Jayasinghe (10035879), Priyani Wanigasekara (10035882), Ajith Sominanda (10035885)   +4 more
core   +1 more source

The Association Between the Composite Dietary Antioxidant Index and Frailty Symptoms: Mediating Effects of Oxidative Stress

Clinical Interventions in Aging
Yue Wu,1 Siqi Cheng,1 Shaoyuan Lei,2 Dongxiao Li,3 Zhongzhong Li,4 Yansu Guo1,2,5 1Beijing Geriatric Healthcare Center, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Evidence-Based Medicine, Xuanwu ...
Wu Y, Cheng S, Lei S, Li D, Li Z, Guo Y
doaj  

Impact of dietary antioxidants on female infertility risk: evidence from NHANES

Scientific Reports
The composite dietary antioxidant index (CDAI) serves as a valuable instrument for evaluating the intake of dietary antioxidants. This research aims to clarify the connection between CDAI and the risk of female infertility by analyzing data from the ...
Yifeng Shao, Lisha Ma, Jianqing Zhou, Kang Wu, Xuedong Tang   +4 more
doaj   +1 more source

Composite dietary antioxidant index is inversely and nonlinearly associated with cardiovascular disease, atherosclerotic cardiovascular disease, and cardiovascular mortality in people with dyslipidemia: evidence from NHANES 2001–2018

Frontiers in Nutrition
BackgroundDyslipidemia is a major risk factor for cardiovascular disease (CVD) and atherosclerotic CVD (ASCVD). The composite dietary antioxidant index (CDAI), an emerging measure of combined dietary antioxidant exposure, may provide insights into the ...
Yan Jiang, Yingying Shen
doaj   +1 more source

Efficacy of Interleukin‐12/23 and Interleukin‐23 Inhibitors for Moderately to Severely Active Crohn's Disease in Advanced Treatment Failure Populations: Systematic Review and Network Meta‐Analysis

JCC Plus, Volume 1, Issue 5, September 2026.
ABSTRACT Background and Aims Earlier trials of advanced treatments indicated for moderately to severely active Crohn's disease used predominantly re‐randomized induction responder designs, whereas newer treatments were evaluated using treat‐through designs.
Christopher Ma, Marla Dubinsky, Gil Y. Melmed, Namita Joshi, Jenny Griffith, Fernando Aponte, Brooke Kim, Eric B. Collins, Kristen Westerhoff, Remo Panaccione   +9 more
wiley   +1 more source

Additional file 1 of Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study

, 2023
Additional file 1. Figure S1. Mean changes from baseline at Month 6 and Month 12 in CDAI score biologic-naïve and biologic-experienced patients receiving IV golimumab with and without methotrexate (observed data). Figure S2. Proportions of biologic-naïve
Shawn Black (15280853), Wayne Langholff (5802701), Douglas Conaway (15280847), Natalie J. Shiff (15280850), Sergio Schwartzman (5327951), Stephen Xu (3606377), Aaron Broadwell (15280841), Jeffrey R. Curtis (7025551), Alan Kivitz (518748), Joy Schechtman (15280844)   +9 more
core   +1 more source